BOTOTLSJU
MDNA

Board of Trustees of The Leland Stanford Junior University’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History

Board of Trustees of The Leland Stanford Junior University’s Portfolio MDNA Stock Details MDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-962,932
Closed -$2.9M – 48
2021
Q2 		$2.9M Hold
962,932
– – 0.27% 17
2021
Q1 		$3.91M Buy
+962,932
New +$3.92M 0.35% 13

Other funds holding MDNA

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
IIM
Intact Investment Management Montreal, Quebec, Canada $3.52B AUM 37.29% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Board of Trustees of The Leland Stanford Junior University's MDNA Position: Q3 2021 in Review

Board of Trustees of The Leland Stanford Junior University sold out of Medicenna Therapeutics Corp. Common Shares (MDNA) in Q3 2021, closing a stake of 962,932 shares — an estimated $2.9M sold.

Board of Trustees of The Leland Stanford Junior University first reported a position in MDNA in Q1 2021 and held it in 2 quarters. The position peaked at $3.91M in Q1 2021. 25 funds tracked by Wall St. Rank hold MDNA as of Q3 2021.

  • Board of Trustees of The Leland Stanford Junior University reported no remaining Medicenna Therapeutics Corp. Common Shares position as of Q3 2021 after selling out during the quarter.
  • Board of Trustees of The Leland Stanford Junior University sold 962,932 Medicenna Therapeutics Corp. Common Shares shares in Q3 2021, an estimated $2.9M.
  • Board of Trustees of The Leland Stanford Junior University first reported a position in Medicenna Therapeutics Corp. Common Shares in Q1 2021 and held it in 2 quarters.
  • Board of Trustees of The Leland Stanford Junior University's Medicenna Therapeutics Corp. Common Shares position peaked at $3.91M in Q1 2021.
  • 25 funds tracked by Wall St. Rank held Medicenna Therapeutics Corp. Common Shares as of Q3 2021.

Based on Board of Trustees of The Leland Stanford Junior University's 13F filing for Q3 2021, filed 12 Nov 2021.